Robert Gadimian is a veteran in the pharmaceutical industry, specializing in pharmaceutical-related procedures for over 20 years. He leads a developmental team that deals with the requirements for developing new drugs. Robert Gadimian is also a member of the Regulatory Affairs Professionals Society (RAPS).
RAPS was founded in 1976 and is one of the largest organizations responsible for the regulation of healthcare-based products. RAPS is an organization with different branches across the globe. However, their headquarters is situated in Washington, DC.
RAPS regulates medical devices, biologics, and pharmaceutical products often used in the healthcare industry. Apart from drug regulation, RAPS also offers education and training for individuals to meet professional standards. It also publishes works based on their discoveries. RAPS frequently hosts career development opportunities. One of the methods through which RAPS promotes career opportunities is Regulatory Affairs Certification, a post-academic credential in the pharmaceutical regulatory field that most regulatory experts view as excellent.
